ANTX$4.11-5.52%
AN2 Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$155.1M
Float & O/S:32.35M / 37.74M
Inst Own:65.1%
DilutionScan read 53 of AN2 Therapeutics, Inc.'s SEC filings and found 2 warrant series, 2 ATM programs, 2 shelf registrations and 1 completed offering on file for ANTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.
